Centers for Disease Control and Prevention donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page CDC
Websitehttp://www.cdc.gov
Twitter usernameCDCgov
Wikipedia pagehttps://en.wikipedia.org/wiki/Centers_for_Disease_Control_and_Prevention
Instagram usernameCDCgov

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 26 373,358 1,308,710 -68,611 50,000 130,740 154,548 254,559 373,358 1,124,711 1,908,550 2,739,487 3,999,569 4,974,967
Global health 26 373,358 1,308,710 -68,611 50,000 130,740 154,548 254,559 373,358 1,124,711 1,908,550 2,739,487 3,999,569 4,974,967

Donation amounts by donor and year for donee Centers for Disease Control and Prevention

Donor Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Bill and Melinda Gates Foundation (filter this donee) 34,026,448.75 254,559.00 155,068.00 2,367,845.00 1,626,640.00 5,612,376.00 8,457,644.00 1,124,711.00 5,682,230.00 5,378,457.00 3,266,918.75 100,000.00
Total 34,026,448.75 254,559.00 155,068.00 2,367,845.00 1,626,640.00 5,612,376.00 8,457,644.00 1,124,711.00 5,682,230.00 5,378,457.00 3,266,918.75 100,000.00

Full list of donations in reverse chronological order (26 donations)

DonorAmount (current USD)Amount rank (out of 26)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation254,559.00112018-09-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation18,591.0022017-11-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
Bill and Melinda Gates Foundation136,477.0072017-11-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to perform the laboratory analysis for Inactivated Polio Virus (IPV) clinical trials; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation373,358.00132016-09-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to perform the laboratory analysis for inactivated polio vaccine (IPV) pre-clinical studies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation154,548.0082016-08-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
Bill and Melinda Gates Foundation1,908,550.00192016-05-02Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the lab work related to serum neutralization assays and viral shedding analyses of the samples from clinical trials (comparator trials and phase I and II trials with the investigational vaccine) for the novel Oral Polio Vaccine development prog; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-68,611.0012016-04-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify the best immunization policy to support the eradication of polio in the world.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation174,000.0092015-11-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct an assessment at WHO regional and HQ levels to identify the best approach for strengthening the WHO regional level data system for routine and measles immunization data; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation74,614.0042015-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate genetic stability of Sabin type 2 poliovirus and develop a direct detection algorithm for the detection of poliovirus in stool specimens for application in the new oral polio vaccine clinical development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation268,370.00122015-11-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
Bill and Melinda Gates Foundation1,109,656.00152015-06-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation4,974,967.00262014-10-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to strengthen immunization systems by building capacity of sub-national immunization program staff, thereby reducing the number of mothers and infants who die during and immediately after birth; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified; affected countries: Ethiopia|Uganda.
Bill and Melinda Gates Foundation130,740.0062014-09-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify the best immunization policy to support the eradication of polio in the world.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation506,669.00142014-06-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to conduct testing for polio neutralizing antibodies in dried blood spots collected in the Democratic Republic of Congo Demographic Health Survey and provide insight into immunity gaps, at-risk populations & operational program efficacy, guide program dec; Aid type: Project-type interventions. Affected countries: Congo (the democratic republic of the).
Bill and Melinda Gates Foundation50,000.0032013-11-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation4,283,479.00252013-11-12Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to strengthen immunization systems by building capacity of sub-national immunization program staff, thereby reducing the number of mothers and infants who die during and immediately after birth; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified; affected countries: Ethiopia|Uganda.
Bill and Melinda Gates Foundation200,115.00102013-10-15Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to validate a qualitative enzyme-linked immunoassay (EIA) for measurement of poliovirus population immunity in endemic countries and in countries at risk of importation worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,739,487.00212013-08-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to achieve global polio eradication by decreasing the threat of polio virus importation and potential transmission in Africa by strengthening routine immunization and increasing the national capacity to detect and respond to polio outbreaks; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,184,563.00172013-04-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify the best immunization policy to support the eradication of polio in the world.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,124,711.00162012-09-21Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop the strategy for onchocerciasis elimination in Africa building on the roll out of NTD mass drug administration programs; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation1,682,661.00182011-11-18Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI); Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation3,999,569.00242011-11-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to achieve global polio eradication by decreasing the threat of polio virus importation and potential transmission in Africa by strengthening routine immunization and increasing the national capacity to detect and respond to polio outbreaks; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,989,588.00222010-11-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to measure the public health benefits of integrated NTD programs and to correlate expanded disease-specific indicators with other health outcomes; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,388,869.00202010-10-26Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop the strategy for onchocerciasis elimination in Africa building on the roll out of NTD mass drug administration programs; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation3,266,918.75232009-11-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to generate information on the impact of a Japanese encephalitis vaccination program, using a safe, affordable Japanese encephalitis vaccine produced by a developing country manufacturer, and to support expanded use of the vaccine; Aid type: Project-type interventions. Affected regions: Asia.
Bill and Melinda Gates Foundation100,000.0052008-10-16Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a safe and effective polio strain for use in an inactivated vaccine by modifying codon usage patterns in polio strains to control viral mutation rates, lower infectivity, and raise genetic stability.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.